🔴 HIMS is trading 4.2% down today as profit-taking extends its post-rally pullback

HIMS is trading 4.2% down at $34.66, extending a sharp two-day pullback following last week’s powerful rally.

• The decline follows a significant run-up driven by positive sentiment surrounding its Novo Nordisk weight-loss drug partnership and eased patent concerns.
• With no fresh company-specific news today, the move appears driven by profit-taking and technical retracement amid a broadly weaker U.S. equity market.